Lc. Gerstenfeld et al., VARIABLE HORMONE RESPONSIVENESS OF OSTEOBLAST POPULATIONS ISOLATED ATDIFFERENT STAGES OF EMBRYOGENESIS AND ITS RELATIONSHIP TO THE OSTEOGENIC LINEAGE, Endocrinology, 137(9), 1996, pp. 3957-3968
A variable response to 1,25-dihydroxyvitamin D-3 [1,25-(OH)(2)D-3] hor
mone treatment was observed for osteoblast cell populations isolated f
rom 12- and 17-day-old embryonic chick calvariae. The younger embryoni
c cell population showed 2- and 5-fold inductions of osteocalcin and o
steopontin gene expression, respectively, and a 25% inhibition of coll
agen gene expression when treated with 1,25-(OH)(2)D-3. In contrast, t
hese same genes all displayed approximately 80% inhibition of their ex
pression when the older embryonic cell populations were treated with h
ormone. The hormone response was related to the appearance of the vita
min D-3 receptor (VDR) and the developmental state of the two cell pop
ulations by assessing the numbers of cells cells that were immunologic
ally labeled for two osteoblast lineage, stage-specific surface makers
(alkaline phosphatase and SB-5, an osteocyte marker) and the VDR. Usi
ng the sequence of marker presentation, with VDR appearing first, foll
owed by alkaline phosphatase and then SB-5, models were tested using l
ogistic regression analysis to validate this order of marker presentat
ion and establish that the two embryonic ages of the cell populations
represent discrete stages of their lineage. This analysis indicated th
at 1,25-(OH)(2)D-3 treatment progressed the la-day-old embryo cell pop
ulations along their lineage and that the hormone promoted the appeara
nce of its own receptor (P < 0.001) However, the appearance of the VDR
does not appear to be a determinant in the variable responses of the
different embryonic aged cell populations to the hormone. These data q
uantitatively establish the unique nature of osteoblast cell populatio
ns within their lineage progression for cells isolated from embryos of
different ages, such that cell populations isolated from younger embr
yos are comprised of primarily presumptive or immature osteoblasts, wh
ereas cells isolated from older embryos are comprised of mature osteob
lasts. These data also demonstrate that the genomic effects of 1,25-(O
H)(2)D-3 are dependent on the developmental stage of the osteoblast li
neage, and the stimulatory actions of the hormone are targeted to imma
ture osteoblasts, whereas the effect of the hormone on mature osteobla
sts is inhibitory.